glp-1 drugs definition Comparing Ozempic, Wegovy and Other GLP-1 Agonists: A Comprehensive Overview

GLP-1 Companion System 7 Packs of Wellness Patches

Harvard geneticist David Sinclair reveals a rare but serious blindness risk linked to GLP-1 drugs, estimating 20,00030,000 NAION cases per year in

Regulates appetite and blood sugar

As a result, they are effective treatment options for people with T2D, achieving glycated haemoglobin reductions, weight loss and potential cardiovascular benefit, as monotherapy or as add-on to other glucose-lowering therapies

The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.

Partner with GenScript today to advance your GLP-1 based therapeutics.